Diagnosis of FCMD typically involves a combination of clinical evaluation, genetic testing, and neuroimaging. Genetic testing is paramount for identifying mutations in the fukutin gene. Additionally, MRI scans can reveal characteristic brain abnormalities, while muscle biopsies may show dystrophic changes and defective glycosylation of alpha-dystroglycan.
